The2024 ACMT Board Review Course is back with an innovative twist for your learning experience! This online course is designed to prepare all examinees for the biennial certification examination in Medical Toxicology administered by the American Board of Emergency Medicine (ABEM). Led by prominent experts in the field of medical toxicology, you will receive a broad overview of the scope of the specialty and a detailed perspective into current clinical and public health toxicological issues.
1. Identify and review core topic areas in the specialty of Medical Toxicology.
2. Prepare for common test questions and terms that may be found on a Medical Toxicology certification exam.
3. Discuss initial management and standard treatment approaches of patients with toxicologic issues.
Get prepared for the ABEM certification exam with our new Flipped Classroom format - the ultimate fusion of convenience, flexibility, and interactivity. In a departure from conventional learning approaches, our Flipped Classroom (a blended learning format) will give you access to a comprehensive array of 30+ meticulously curated on-demand lectures encompassing the entire spectrum of medical toxicology. This enriched content will be at your disposal June 1, 2024 - May 31, 2025, empowering you to proceed with your studies at a pace that aligns with your commitments.
In addition to the autonomous learning, prepare to be part of 7 live, interactive cram sessions throughout the summer and early fall. Focused on 4-5 core topics during each session, these power-packed sessions are your golden ticket to in-depth insights, key takeaways, and invaluable Q&A with our experts.
Our top-notch speakers are ready to guide you through each lecture, ensuring you grasp every critical concept. These lectures are pre-recorded so you can access them anytime, anywhere and as many times as you want until you are confident in each subject area. Immerse yourself in a learning journey with lectures that drill down into each aspect of the Medical Toxicology Core Content including:
Cancellations made on or before May 16, 2024 will receive a full refund less an 8% processing fee. Cancellations made after this date will not receive a refund. Limited exceptions may be considered for emergency situations pending review.
All cancellation requests must be made in writing and emailed to:
eve...@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to
eve...@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.
When you register for this course, we'll arm you with an arsenal of study resources. Dive into the Quiz Bank to put your knowledge to the test, flip through flashcards for rapid-fire revision, and explore visual stimuli to enhance your understanding. The ACMT Board Review Course includes:
Disclaimer: according to ABEM policy, the planning committee and faculty for this course are not allowed to have intimate knowledge of the exam or write exam questions. The content of this course is based on the expertise of ACMT members, who are specialists in Medical Toxicology. We do not have direct knowledge of the exam content. ABEM test question writers are prohibited from participating in any board review or preparatory course. The study materials, including the Quiz Bank questions, are based on years of collective experience from the Board Review Course committee, but we do not guarantee that these questions fully represent the exam content.
Activity Overview
The 2024 ACMT Board Review Course is back with an innovative twist for your learning experience! This online course is designed to prepare all examinees for the biennial certification examination in Medical Toxicology administered by the American Board of Emergency Medicine (ABEM). Led by prominent experts in the field of medical toxicology, you will receive a broad overview of the scope of the specialty and a detailed perspective into current clinical and public health toxicological issues.
Criteria for Success
Statements of credit will be awarded based on the participant's attendance. A statement of credit will be available upon completion of all on-demand lectures, the 100 Q Practice Test, and CE Survey.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to
opt...@akhcme.com with your information with "Opt Out" in the subject line.
Dr. Michele Burns is triple boarded in general pediatrics, pediatric emergency medicine, and medical toxicology. She has been the Medical Director of the Massachusetts and Rhode Island Poison Center for the last 20 years and is Chief of the Boston Children's Hospital Toxicology service. Her clinical research interests include investigating the epidemiological trends of pediatric poisoning exposures by using large hospital or national databases, and clinical communications that describe novel and innovative case presentations and/or treatment modalities in the pediatric toxicology patient. In addition, she is the Harvard Medical Toxicology Fellowship Director and a former member of both the ACMT Board and ABEM Medical Toxicology Subboard. Dr. Burns is also the Pediatric Toxicology Section Editor for UptoDate. She is committed to promoting optimal health care for acutely injured and poisoned patients, advocating for state-of-the-art treatment while contributing to national consensus guidelines and prevention efforts on a more global level.
Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.
Dr. Hantsch is a graduate of the Honors Program in Medical Education at Northwestern University. She completed an emergency medicine residency, including a year as chief resident, at the Medical College of Wisconsin and then continued her training in a medical toxicology fellowship at Vanderbilt University. After her fellowship, she spent nearly 22 years at Loyola University Chicago Stritch School of Medicine and Loyola University Medical Center. There, she established an inpatient toxicology clinical service and clinical rotations for graduate medical trainees and students in multiple fields. With an interest in medication management and safety, she joined the hospital Pharmacy and Therapeutics Committee, serving as member for 6 years before being appointed chair and leading the committee for another 6 years. Dr. Hantsch earned the academic rank of Professor of Emergency Medicine, was Director of the Division of Toxicology, and Director of Academic Affairs in the Department of Emergency Medicine. As a clinical faculty member, she was appointed to the Stritch Committee on Academic Rank and Tenure, serving for 7 years including 2 as a subcommittee chair leading revision of the clinician educator track guidelines. In 2018, she was the founding Program Director of the Loyola emergency medicine residency. Dr. Hantsch served for more than 8 years as Medical Director of the Illinois Poison Center. In addition, she is a regular organizer and contributor to many local, regional, and national/international continuing education programs. After leaving academics, she worked for the U.S. FDA in pharmacovigilance for a year. As of 2022, she is board certified in addiction medicine in addition to emergency medicine and medical toxicology. Dr. Hantsch was elected to the ACMT Board of Directors in 2021, is a member of the Education Committee, and chair of the Practice Committee.
3a8082e126